
FDA Chief Recognizes Slow Progress On CBD Regulations
Dr. Robert M. Califf confirmed on Thursday at a congressional panel that the FDA has made little progress on the regulatory framework around CBD products over the years since Trump signed the Farm Bill in late 2018.